Literature DB >> 177271

Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin.

F Vignon, H Rochefort.   

Abstract

The "ovarian-dependent" rat mammary tumors, induced by 9,10 dimethyl-1,2-benzanthracene, were assayed for their estrogen receptor content by dextran-coated charcoal adsorption and sucrose gradient ultra-centrifugation. The estradiol receptors bound estrogens with a high affinity (KD approximately 0.25 nM), limited capacity and high specificity, and sediment at 8 S in a sucrose gradient. The cytosol receptors were transferred to the nucleus after binding to estrogens either in vivo or in vitro. The tumor area regressed by 70% during the first 10 days of castration while the concentration of estradiol cytosol receptors decreased from 225 to 16 fmoles/mg of protein. Three to five days after in vivo administration of estradiol (2 mug daily) or prolactin (1 mg daily) the concentration of estrogen receptors was increased in spayed rats. In biopsy experiments, prolactin, but not estradiol, was shown to increase the estrogen receptor concentration when endogenous prolactin release was blocked by CB 154. Prolactin did not modify the intracellular distribution of the estrogen receptor or its binding affinity for estrogen. The uterine estrogen receptor sites were not modified by prolactin under the same conditions. We, therefore, suggest that in mammary tumors prolactin sensitizes the action of estrogens at the target level by increasing the concentration of their available receptor sites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177271     DOI: 10.1210/endo-98-3-722

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.

Authors:  P M Martin; P H Rolland; J Jacquemier; A M Rolland; M Toga
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Treatment of benign breast disease with bromocriptine.

Authors:  A Mussa; L Dogliotti
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

3.  Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: a 200-patient study.

Authors:  N Bressot; F Veith; J Saussol; H Pujol; M Lavie; M Granier; J Gary-Bobo; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

4.  Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.

Authors:  F Di Carlo; G Conti; M Giubertoni; G Muccioli; S Racca
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Role of steroid hormones and morphine treatment in the modulation of opioid receptor gene expression in brain structures in the female rat.

Authors:  Wesley Soares Cruz; Lucas Assis Pereira; Luana Carvalho Cezar; Rosana Camarini; Luciano Freitas Felicio; Maria Martha Bernardi; Elizabeth Teodorov
Journal:  Springerplus       Date:  2015-07-16

6.  Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

Authors:  R A Hawkins; A L Tesdale; E D Anderson; P A Levack; U Chetty; A P Forrest
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.